Micro- and nanotechnology for HIV/AIDS diagnostics in resource-limited settings

Gregory L. Damhorst, Nicholas N. Watkins, Rashid Bashir

Research output: Contribution to journalReview article

Abstract

Thirty-four million people are living with HIV worldwide, a disproportionate number of whom live in resource-limited settings. Proper clinical management of AIDS, the disease caused by HIV, requires regular monitoring of both the status of the host's immune system and levels of the virus in their blood. Therefore, more accessible technologies capable of performing a CD4+ T cell count and HIV viral load measurement in settings where HIV is most prevalent are desperately needed to enable better treatment strategies and ultimately quell the spread of the virus within populations. This review discusses micro- and nanotechnology solutions to performing these key clinical measurements in resource-limited settings.

Original languageEnglish (US)
Pages (from-to)715-726
Number of pages12
JournalIEEE Transactions on Biomedical Engineering
Volume60
Issue number3
DOIs
StatePublished - Oct 1 2013

Fingerprint

Viruses
Nanotechnology
T-cells
Immune system
Blood
Monitoring

Keywords

  • Global health
  • Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)
  • Micro- and nanotechnology
  • Point-of-care (PoC) diagnostics

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Micro- and nanotechnology for HIV/AIDS diagnostics in resource-limited settings. / Damhorst, Gregory L.; Watkins, Nicholas N.; Bashir, Rashid.

In: IEEE Transactions on Biomedical Engineering, Vol. 60, No. 3, 01.10.2013, p. 715-726.

Research output: Contribution to journalReview article

@article{49db5990387f4025a5c0c688c54e2cf2,
title = "Micro- and nanotechnology for HIV/AIDS diagnostics in resource-limited settings",
abstract = "Thirty-four million people are living with HIV worldwide, a disproportionate number of whom live in resource-limited settings. Proper clinical management of AIDS, the disease caused by HIV, requires regular monitoring of both the status of the host's immune system and levels of the virus in their blood. Therefore, more accessible technologies capable of performing a CD4+ T cell count and HIV viral load measurement in settings where HIV is most prevalent are desperately needed to enable better treatment strategies and ultimately quell the spread of the virus within populations. This review discusses micro- and nanotechnology solutions to performing these key clinical measurements in resource-limited settings.",
keywords = "Global health, Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), Micro- and nanotechnology, Point-of-care (PoC) diagnostics",
author = "Damhorst, {Gregory L.} and Watkins, {Nicholas N.} and Rashid Bashir",
year = "2013",
month = "10",
day = "1",
doi = "10.1109/TBME.2013.2244894",
language = "English (US)",
volume = "60",
pages = "715--726",
journal = "IEEE Transactions on Biomedical Engineering",
issn = "0018-9294",
publisher = "IEEE Computer Society",
number = "3",

}

TY - JOUR

T1 - Micro- and nanotechnology for HIV/AIDS diagnostics in resource-limited settings

AU - Damhorst, Gregory L.

AU - Watkins, Nicholas N.

AU - Bashir, Rashid

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Thirty-four million people are living with HIV worldwide, a disproportionate number of whom live in resource-limited settings. Proper clinical management of AIDS, the disease caused by HIV, requires regular monitoring of both the status of the host's immune system and levels of the virus in their blood. Therefore, more accessible technologies capable of performing a CD4+ T cell count and HIV viral load measurement in settings where HIV is most prevalent are desperately needed to enable better treatment strategies and ultimately quell the spread of the virus within populations. This review discusses micro- and nanotechnology solutions to performing these key clinical measurements in resource-limited settings.

AB - Thirty-four million people are living with HIV worldwide, a disproportionate number of whom live in resource-limited settings. Proper clinical management of AIDS, the disease caused by HIV, requires regular monitoring of both the status of the host's immune system and levels of the virus in their blood. Therefore, more accessible technologies capable of performing a CD4+ T cell count and HIV viral load measurement in settings where HIV is most prevalent are desperately needed to enable better treatment strategies and ultimately quell the spread of the virus within populations. This review discusses micro- and nanotechnology solutions to performing these key clinical measurements in resource-limited settings.

KW - Global health

KW - Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS)

KW - Micro- and nanotechnology

KW - Point-of-care (PoC) diagnostics

UR - http://www.scopus.com/inward/record.url?scp=84884355957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884355957&partnerID=8YFLogxK

U2 - 10.1109/TBME.2013.2244894

DO - 10.1109/TBME.2013.2244894

M3 - Review article

C2 - 23512111

AN - SCOPUS:84884355957

VL - 60

SP - 715

EP - 726

JO - IEEE Transactions on Biomedical Engineering

JF - IEEE Transactions on Biomedical Engineering

SN - 0018-9294

IS - 3

ER -